Single-Chamber Prefilled Syringes Market to Reach $22.05 Billion by 2029 at 16.5% CAGR

 This report provides practical insights for business leaders looking to understand market growth, size, and key trends in the single-chamber prefilled syringes industry.

 

 What Is The Projected Market Size & Growth Rate Of The Single-Chamber Prefilled Syringes Market?
 The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $10.72 billion in 2024 to $11.97 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to growth in pharmaceutical and biotechnology sectors, patient-friendly drug administration, safety and ease of use, demand for precise drug dosing, regulatory approvals and guidelines.
 
 The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $22.05 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to biologics and biosimilars in prefilled syringes, self-administration and home healthcare, pediatric and geriatric drug delivery, combination products with auto-injectors, regulatory emphasis on drug safety, telemedicine and remote monitoring. Major trends in the forecast period include prefilled syringes with connected devices, sustainable and biodegradable materials, customized and patient-specific syringe options, needlestick prevention and safety features, prefilled syringes for cell and gene therapies, prefilled syringes with anti-counterfeiting measures.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp
  
 What Is The Crucial Factor Driving The Global Single-Chamber Prefilled Syringes Market?
 The growing prevalence of chronic diseases such as diabetes and cancer are contributing to the growth of the single-chamber prefilled syringe market. Diabetes patients who require insulin therapy when medicines cannot control their blood glucose levels use the single-chamber prefilled syringe. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, by 2050, over 35 million new cancer cases are projected, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases such as diabetes and cancer drives the market for single-chamber prefilled syringes.
 
 Segment Covered In The Single-Chamber Prefilled Syringes Market Report
 The single-chamber prefilled syringes market covered in this report is segmented — 
 
 1) By Type: Glass, Plastic 
 2) By Application: Vaccine Product, Biologic, Pharmaceutical Product 
 
 Subsegments:
 1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
 2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
 
 Key Trends Driving Growth In The Single-Chamber Prefilled Syringes Market
 Growing technological advancements are shaping the single-chamber prefilled syringe market. Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position. For instance, in September 2022, Otsuka America Pharmaceutical, Inc., a US-based healthcare company, and H. Lundbeck A/S, a Danish international pharmaceutical company, introduced Aripiprazole 2-month. It comes in a single-chamber, prefilled syringe and is a 2-month, ready-to-use, long-acting injectable form of aripiprazole. The gluteal muscle is where it is to be injected intramuscularly every two months for the dosage.
 
 Key Player In The Single-Chamber Prefilled Syringes Market
 Major companies operating in the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd. 
 
 View the full single-chamber prefilled syringes market report here:
 https://www.thebusinessresearchcompany.com/report/single-chamber-prefilled-syringes-global-market-report
 
 Global Single-Chamber Prefilled Syringes Market — Regional Insights:
 North America was the largest region in the single-chamber prefilled syringes market in 2024. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company